Here’s how NSIV members completed this phrase: “You know you’re an entrepreneur IF….”Read more
The Boston Business Journal reports on the important issue of bridging the gap between academia and biotechnology businesses in a two-part series on the EurekaConnect event held September 24th and 25th in Boston. Dr. Martha Farmer, CEO and President of NSIV, was a participant.Read more
Quad Technologies Inc (“Quad”), developer of a novel cell separation technology, has secured a substantial amount of capital from its Series A round to accelerate development of disruptive cell processing technologies for translational medicine applications. The investment has enabled Quad to launch its MagCloudz™ Streptavidin Cell Separation Kit, which is the first commercially available productRead more
Microbeads: A Green Alternative -TerraVerdae BioWorks gears up for production using a proprietary process that successfully produces non-petroleum-based plastics that safely biodegrade.Read more
State energy officials announced today that awards totaling $530,000 will be given to four Massachusetts small business cleantech incubators. North Shore InnoVentures will receive $165,000 over a three-year period. Other awardees include Chesnut Innovation Center (Amesbury), Greentown Labs (Somerville), and TechSandBox (Hopkinton).Read more
SolidEnergy, the developer of the “anode-free” battery delivering ultra high energy density and safety with 1200 Wh/L and 400 Wh/kg, announced that it has raised $12M in a Series B round. “Strategic investments will help us build an ecosystem around our anode-free battery by establishing partnerships with equipment suppliers, battery manufacturers and battery end users,”Read more
CrowdComtfort is among Boston area clean-tech companies that are glad to see General Electric locate its new energy division in Boston. Current has temporarily located in the WeWork co-working space near South Station. Read more about what Eric Graham and others are saying about the significance of this development in the Boston Globe article.Read more
Former NSIV member Atentiv is making news with an announcement that it has a game in clinical trials designed to be used instead of medication for kids with ADHD. “We’re not using chemicals to effect the neurons, we’re rewiring the circuit… that rewiring is learning,” said Eric Cordon, CEO of Atentiv. The medical game isRead more
Interested in incubating your company with InnoVenture Labs? Submit your application today!